![]() Clinical TrialsNSABP B-41Breast CancerA Randomized Phase III Trial of Neoadjuvant Therapy for Patients with Palpable and Operable HER2-Positive Breast Cancer Comparing the Combination of Trastuzumab Plus Lapatinib to Trastuzumab and to Lapatinib Administered with Weekly Paclitaxel Following AC Accompanied by Correlative Science Studies to Identify Predictors of Pathologic Complete Response Click here to apply for this clinical trial. Click here to view all clinical trials for this cancer type. |
The Novalis Tx is HereNow even those with previously untreatable tumors have new hope for healing.Click here for more. Seven Levels of HealingA ground-breaking education and support program now offered at multiple RMCC locations.Click here for more. ![]() CONTACT US888-259-RMCC (7622) |


